GE HealthCare invests $138 million in Cork, Ireland manufacturing facility to address increasing contrast media demand ...

Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...

With this approval, ARCALIS’s Minami-soma facilities and Meiji Seika Pharmatech Co., Ltd., a subsidiary of Meiji Seika Pharma, have been added as manufacturing sites. The technology transfer was ...

This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq ... today announced that the company will present three posters for its lead therapeutic candidate, efzofitimod, at the ...

Contact: Ashlee Dunston Sr. Director, Investor Relations and Public Affairs [email protected] Source: aTyr Pharma, Inc. The views and opinions expressed herein are the views and opinions of ...

In this article, Ben Hargreaves asks whether there is particular potential for the technologies to revolutionise staff training and reduce costs in pharma manufacturing. Virtual reality (VR ...

SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR ... today announced that the company will present three posters for its lead therapeutic candidate, efzofitimod, at the ...

topline data from the study expected in the third quarter of 2025 Current epidemiology and treatment practices for pulmonary sarcoidosis in the U.S. based on real-world evidence SAN DIEGO, Jan. 29, ...

Preliminary details of the poster presentations appear below ... timing and results of EFZO-FIT™, and the epidemiology and treatment practices for pulmonary sarcoidosis in the U.S. These ...